Breaking News Instant updates and real-time market news.

PYPL

PayPal

$77.22

-1.8 (-2.28%)

20:49
10/15/18
10/15
20:49
10/15/18
20:49

PayPal earnings to highlight continued account growth momentum, says Stifel

Stifel analyst Scott Devitt kept his Buy rating and $102 price target on Paypal ahead of its Q3 earnings this Thursday, saying the company should produce "continued momentum from healthy net active account additions, solid Venmo total payment volume, or TVP, growth, and further expansion in emerging geographies." The analyst anticipates TPV and revenue growth of 25% and 14% respectively and sees Paypal as "well-positioned for long-term growth given the secular tailwinds in digital payments".

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 26

    Nov

PYPL PayPal
$77.22

-1.8 (-2.28%)

10/12/18
DBAB
10/12/18
NO CHANGE
DBAB
Buy
PayPal recent selloff brings buying opportunity, says Deutsche Bank
Deutsche Bank analyst Bryan Keane views the recent pullback in shares of PayPal as a buying opportunity. He expects the company to provide fiscal 2019 guidance of mid-20% total payment volume growth, mid-teens revenue/non-GAAP operating income growth, as well as slightly expanding operating margin. The analyst keeps a Buy rating on PayPal into the company's Q3 results.
10/11/18
NOMU
10/11/18
NO CHANGE
Target $103
NOMU
Buy
PayPal price target lowered to $103 from $120 at Nomura Instinet
Nomura Instinet analyst Bill Carcache lowered his price target for PayPal Holdings to $103 while keeping a Buy rating on the shares. Investors should "brace themselves" for a slowing in year-over-over currency-neutral cross-border total payment volume growth to 15% in Q3, versus 21% in Q2, Carcache tells investors in a research note. However, he believes PayPal has enough levers at its disposal to hit its growth targets over time. The analyst keeps a Buy rating on the shares.
10/10/18
PIPR
10/10/18
NO CHANGE
Target $94
PIPR
Neutral
Piper boosts Square target to $94, Global Payments target to $157
Piper Jaffray analyst Jason Deleeuw raised his price target for Neutral-rated Square 9SQ) to $94 from $67 in a research previewing the Q3 earnings reports for his FinTech coverage universe. Key fundamental factors for the sector remain positive, including ongoing secular growth and macro cyclical strength, Deleeuw tells investors in a research note. Also, the group's fundamentals are relatively insulated from the key macro risks of rising input costs and tariff escalation, the analyst adds. As such, he expects in-line to better than consensus Q3 results and outlooks, which he thinks will help stabilize the relative valuation multiples for the group. Deleeuw's top ideas into the quarter include Black Knight (BKI), Global Payments (GPN), First Data (FDC), Visa (V), Euronet (EEFT) and Alliance Data (ADS). In addition to Square, the analyst boosted his price target for Overweight-rated Alliance Data to $319 from $312, Neutral-rated American Express (AXP) to $126 from $113, Overweight-rated Global Payments to $157 from $135, Overweight-rated MasterCard (MA) to $216 from $224, Neutral-rated PayPal (PYPL) to $96 from $81 and Overweight-rated Visa to $191 from $166.
10/09/18
WBLR
10/09/18
NO CHANGE
WBLR
Outperform
PayPal recent selloff brings buying opportunity, says William Blair
William Blair analyst Robert Napoli says that while recent acquisitions and the sale of its credit business "could complicate near-term visibility, PayPal's (PYPL) fundamentals remain strong. The 13% drop in PayPal's share price from its highs, taking the valuation to 17 times 2019 EBITDA, brings an attractive entry point for long-term investors, Napoli tells investors in a research note. He believes the company's earnings should grow at a high-teens to 20% rate over the medium term. Ahead of September quarter results on October 18, Napoli lowered his 2020 earnings per share estimate for PayPal to $3.32 from $3.40 to account for the roll-off of the eBay (EBAY) processing business. He keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:28
11/19/18
11/19
16:28
11/19/18
16:28
Earnings
Nuance sees Q1 EPS 27c-29c, consensus 28c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Limbach backs FY18 revenue view $530M-$550M, consensus $541.82M »

Backs FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PSTG

Pure Storage

$17.56

-1.56 (-8.16%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Pure Storage raises FY19 revenue view to $1.376B-$1.384B from $1.35B-$1.38B »

FY19 consensus $1.37B. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Earnings
Limbach reports Q3 EPS (46c) vs (12c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EBS

Emergent BioSolutions

$69.73

-1.36 (-1.91%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Hot Stocks
Emergent BioSolutions and VLAS report 'positive' trial results for Zika vaccine »

Emergent BioSolutions and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 12

    Dec

NVLN

Novelion Therapeutics

$1.00

0.0192 (1.96%)

16:25
11/19/18
11/19
16:25
11/19/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Novelion Therapeutics »

NB Public Equity reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$4.55

-0.14 (-2.99%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
Hot Stocks
Akoustis announces first 5.2 HGz WiFi pre-production order »

Akoustis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 11

    Dec

  • 12

    Dec

AAPL

Apple

$185.80

-7.62 (-3.94%)

, FB

Facebook

$131.62

-7.93 (-5.68%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
OnTheFly
Fly Intel: Wall Street's top stories for Monday »

Stocks opened in negative…

AAPL

Apple

$185.80

-7.62 (-3.94%)

FB

Facebook

$131.62

-7.93 (-5.68%)

NSANY

Nissan

$0.00

(0.00%)

REN

Resolute Energy

$34.72

4.21 (13.80%)

XEC

Cimarex Energy

$88.03

-0.6 (-0.68%)

NIO

NIO Inc.

$7.81

0.63 (8.77%)

CFX

Colfax

$23.72

-4.285 (-15.30%)

BX

Blackstone

$31.78

-0.7 (-2.16%)

MDLZ

Mondelez

$44.45

0.17 (0.38%)

CPB

Campbell Soup

$38.47

-0.17 (-0.44%)

JD

JD.com

$21.09

-1.95 (-8.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

DERM

Dermira

$9.73

0.04 (0.41%)

16:22
11/19/18
11/19
16:22
11/19/18
16:22
Upgrade
Dermira rating change  »

Dermira assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$48.42

-0.58 (-1.18%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Hot Stocks
Thomson Reuters receives shareholder approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 19th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUS

Bellus Health

$0.00

(0.00%)

16:19
11/19/18
11/19
16:19
11/19/18
16:19
Conference/Events
Bellus Health to host conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORPN

Bio Blast Pharma

$1.19

-0.02 (-1.65%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Bio Blast Pharma to acquire Enlivex Therapeutics »

Bioblast Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCRH

QCR Holdings

$36.85

-0.34 (-0.91%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
QCR Holdings says Douglas Hultquist will retire as CEO, Helling to succeed »

QCR Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAY

Accuray

$4.45

-0.27 (-5.72%)

, DHR

Danaher

$101.29

-1.95 (-1.89%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Accuray names Shig Hamamatsu as CFO, effective immediately »

Accuray (ARAY) announced…

ARAY

Accuray

$4.45

-0.27 (-5.72%)

DHR

Danaher

$101.29

-1.95 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

  • 13

    Dec

JACK

Jack in the Box

$79.66

-0.97 (-1.20%)

16:17
11/19/18
11/19
16:17
11/19/18
16:17
Hot Stocks
Jack in the Box sees FY19 SSS flat to up 2%. »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/19/18
11/19
16:17
11/19/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOS

A.O. Smith

$45.64

-0.34 (-0.74%)

16:16
11/19/18
11/19
16:16
11/19/18
16:16
Initiation
A.O. Smith initiated  »

A.O. Smith initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/19/18
11/19
16:16
11/19/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AME

Ametek

$72.58

-1.72 (-2.31%)

16:14
11/19/18
11/19
16:14
11/19/18
16:14
Initiation
Ametek initiated  »

Ametek initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JACK

Jack in the Box

$79.66

-0.97 (-1.20%)

16:14
11/19/18
11/19
16:14
11/19/18
16:14
Hot Stocks
Jack in the Box reports Q4 company SSS up 0.8% »

Reports Q4 franchise SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

JACK

Jack in the Box

$79.83

-0.8 (-0.99%)

16:13
11/19/18
11/19
16:13
11/19/18
16:13
Hot Stocks
Jack in the Box authorizes additional $60M stock buyback program »

The company repurchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LPLA

LPL Financial

$62.39

-0.58 (-0.92%)

16:13
11/19/18
11/19
16:13
11/19/18
16:13
Hot Stocks
LPL Financial reports total brokerage,advisory assets at October-end down 4.7% »

LPL Financial, a wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$124.97

-7.56 (-5.70%)

16:13
11/19/18
11/19
16:13
11/19/18
16:13
Hot Stocks
GW Pharmaceuticals to present data on Epidiolex at AES »

GW Pharmaceuticals along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ORPN

Bio Blast Pharma

$1.19

-0.02 (-1.65%)

16:12
11/19/18
11/19
16:12
11/19/18
16:12
Hot Stocks
Breaking Hot Stocks news story on Bio Blast Pharma »

Bio Blast Pharma trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.